New-onset Left Bundle Branch Block Independently Predicts Long-term Mortality in Patients with Idiopathic Dilated Cardiomyopathy: Data from the Trieste Heart Muscle Disease Registry
Overview
Physiology
Authors
Affiliations
Aims: Left bundle branch block (LBBB) is commonly associated with heart failure. We evaluated the prevalence, incidence, and impact of LBBB on long-term outcome in young patients with heart failure affected by idiopathic dilated cardiomyopathy (DCM).
Methods And Results: We included 608 patients with DCM from the Heart Muscle Disease Registry of Trieste in this retrospective analysis. At baseline electrocardiogram (ECG), 189 patients (31.1%) had LBBB. The patients with baseline LBBB had a significantly higher mortality rate than the patients without LBBB (38.6 vs. 27.9%, P = 0.002) at the univariate analysis. After a multiple covariate adjustment, the baseline LBBB was not associated with a significantly increased risk of death [hazard ratio (HR) 1.27, 95% confidence interval (CI): 0.88-1.81, P = 0.2]. Forty-seven (11.2%) patients without LBBB at baseline ECG developed LBBB during follow-up. Among these, the mortality rate was 49 vs. 25% in patients without new-onset LBBB (P = 0.001). New-onset LBBB was a strong and independent predictor of all-cause mortality (HR 3.18, 95% CI: 1.90-5.31, P < 0.001) at multivariate analysis.
Conclusion: After correcting for potential confounders, new-onset LBBB was found to be associated with an increased risk of all-cause mortality. The management of patients with new-onset LBBB may need to be more aggressive, possibly including early cardiac resynchronization therapy/implantable cardioverter-defibrillator therapy.
Left Bundle Branch Block-associated Cardiomyopathy: A New Approach.
Ponnusamy S, Vijayaraman P, Ellenbogen K Arrhythm Electrophysiol Rev. 2024; 13:e15.
PMID: 39450115 PMC: 11499974. DOI: 10.15420/aer.2024.14.
Marques C, Cabrita A, Pinho A, Santos L, Oliveira C, Rodrigues R Heart Vessels. 2024; 40(1):62-71.
PMID: 39039344 DOI: 10.1007/s00380-024-02441-2.
Electrocardiographic abnormalities in patients with cardiomyopathies.
Aimo A, Milandri A, Barison A, Pezzato A, Morfino P, Vergaro G Heart Fail Rev. 2023; 29(1):151-164.
PMID: 37848591 PMC: 10904564. DOI: 10.1007/s10741-023-10358-7.
The pivotal role of ECG in cardiomyopathies.
Silvetti E, Lanza O, Romeo F, Martino A, Fedele E, Lanzillo C Front Cardiovasc Med. 2023; 10:1178163.
PMID: 37404739 PMC: 10315483. DOI: 10.3389/fcvm.2023.1178163.
The electrocardiogram in non-ischaemic-dilated cardiomyopathy.
Crescenzi C, Silvetti E, Romeo F, Martino A, Bressi E, Panattoni G Eur Heart J Suppl. 2023; 25(Suppl C):C179-C184.
PMID: 37125290 PMC: 10132560. DOI: 10.1093/eurheartjsupp/suad043.